|
[64Cu]-DOTA-hLM609-II |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-DOTA-2.5F |
64Cu |
Integrin α5β1 receptor |
PET |
|
|
[64Cu]-DOTA-2.5D |
64Cu |
|
PET |
|
|
[64Cu]-DOTA-RGD Octamer |
64Cu |
Integrin αvβ3 recetor |
PET |
|
|
cFLFLFK-PEG-[64Cu] |
64Cu |
N-formylpeptide receptor (FPR) |
PET |
|
|
[64Cu]-DOTA-E{E[c(RGDfK)]2}2 |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-DOTA-PEG-E[c(RGDyK)]2 |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-TETA-OC |
64Cu |
|
PET |
|
|
[64Cu]-TP3939 |
64Cu |
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) receptors (VPAC1) |
PET |
|
|
[64Cu]-DOTA-NAPamide |
64Cu |
Melanocortin-1 (MC-1) receptor |
PET |
|
|
[64Cu]-DOTA-VEGF |
64Cu |
Vascular endothelial growth factor receptors (VEGFR or VEGF receptors) |
PET |
|
|
[64Cu]-MP2346 |
64Cu |
Gastrin-releasing peptide receptor (GRP-R) |
PET |
|
|
[64Cu]-DOTA hu4D5v 8 scFv-Fc DM |
64Cu |
Human epidermal growth factor receptor 2 (HER2) |
PET |
|
|
[64Cu]-WT4351 |
64Cu |
IGF1 receptor (IGF1R) |
PET |
|
|
[64Cu]-LS172 |
64Cu |
Somatostatin receptor subtype-2 (SSTR-2) |
PET |
|
|
[64Cu]-CB-TE2A-c(RGDyK) |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-DOTA-Cetuximab |
64Cu |
EGF receptor (EGFR |
PET |
|
|
[64Cu]-DOTA-PEG-c(RGDyK) |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-DOTA-QD-c(RGDyK) |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-DOTA-c(RGDyK) |
64Cu |
Integrin αvβ3 receptor |
PET |
|
|
[64Cu]-Knottin 2.5F |
64Cu |
αvβ3 |
PET |
|
|
[64Cu]-Knottin 2.5D |
64Cu |
αvβ3 |
PET |
|
